Metal and Mining Stocks Catch A Bid Friday, August 27, 2:38 PM ET, by Market News Video Staff In Friday afternoon trading, the SPDR S&P Metals and Mining ETF (XME) is trading higher ...
Bonds ETFs Soar As Economic Data Weakens Equities Tuesday, August 31, 3:45 PM ET, by Market News Video Staff Over the last several months, a slew of disappointing economic data has caused investors to ...
Almost $8 billion of ExxonMobil Held by ETFs Wednesday, September 29, 11:54 AM ET, by Market News Video Staff According to ETFChannel.com's "Top ETF Stock Components" top list, ETFs aggregately hold approximately $8 billion ...
More Than $2.5 Billion of Qualcomm Held By ETFs Thursday, September 30, 8:21 AM ET, by Market News Video Staff Turning to ETFChannel.com's "Top ETF Stock Components" top-list, ETFs aggregately hold over $2.5 billion of ...
By Market News Video Staff, Thursday, October 7, 8:24 AM ET
Gilead Sciences (NASDAQ:GILD) makes up 23.68% of the Biotech HOLDRS (AMEX:BBH) ETF. The Biotech HOLDRS has a market capitalization of over $777.3 million, meaning that over $184 million of that market cap is tied to Gilead Sciences.
According to ETFChannel.com, there are 63 ETFs that hold Gilead Sciences, and aggregately, those ETFs make up 4.29% of Gilead's total market cap. Other ETFs with large holdings include PowerShares QQQ (QQQQ) with about $359.5 million of Gilead, the SPDR S&P 500 ETF (AMEX:SPY) with $230.35 million and the iShares Nassdaq Biotechnology Index Fund (NASDAQ:IBB) at $79.2 million.
This Article's Word Cloud:AMEXAccordingBiotechBiotechnologyETFChannelETFsFundGILDGileadHOLDRSIndexNASDAQNassdaqOtherPowerSharesQQQQSPDRSciencesaboutaggregatelycapitalizationholdholdingsiSharesincludelargemakemakesmarketmeaningmillionoverthattherethosetiedtotalwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.